- Zepp Health (ZEPP, Financial) posted a first-quarter loss with an earnings per share (EPS) of -$0.06.
- Revenue fell to $39 million, marking a 2% year-over-year decline.
- Analysts maintain an optimistic outlook, projecting an average price target reflecting substantial upside potential.
Zepp Health (ZEPP) recently reported its financial results for the first quarter, revealing a loss with GAAP earnings per share at -$0.06. The company's revenue decreased to $39 million, marking a minor 2% decline compared to the same period last year. Despite these challenges, Zepp Health retained a robust cash balance of $104 million after settling $11.5 million in short-term debt, showcasing its financial resilience.
Wall Street Analysts Forecast
One pivotal aspect for investors is the future price target set by market analysts. According to one-year projections from a single analyst, the average target price for Zepp Health Corp (ZEPP, Financial) is set at $13.87. This target is consistent across the board, as both the high and low estimates match the average. This projection suggests a remarkable upside of 421.32% from the current trading price of $2.66. For more in-depth estimates, investors can visit the Zepp Health Corp (ZEPP) Forecast page.
Moreover, Zepp Health Corp enjoys a positive consensus recommendation from brokerage firms, holding an average brokerage recommendation score of 2.0. This score positions the stock in the "Outperform" category, indicating positive future expectations relative to its peers. The rating scale used ranges from 1 to 5, where 1 denotes a Strong Buy, and 5 indicates a Sell recommendation.
Contrastingly, when examining Zepp Health's valuation through the lens of GuruFocus estimates, the stock's estimated GF Value a year from now is pegged at $2.11. This suggests a potential downside of 20.68% from its current price of $2.66. The GF Value provides a measure of the stock's fair price based on historical trading multiples, past growth, and anticipated future performance. For a thorough analysis, investors may find more detailed insights on the Zepp Health Corp (ZEPP, Financial) Summary page.
